Amgen – In Brief This Week: Janssen, Amgen, Daiichi Sankyo, AstraZeneca, Interpace Biosciences
Amgen reported detailed results this week from the Phase II CodeBreak-100 trial, in which the company is investigating the activity of sotorasib in …
Home » Amgen – In Brief This Week: Janssen, Amgen, Daiichi Sankyo, AstraZeneca, Interpace Biosciences
Amgen – In Brief This Week: Janssen, Amgen, Daiichi Sankyo, AstraZeneca, Interpace Biosciences
Amgen reported detailed results this week from the Phase II CodeBreak-100 trial, in which the company is investigating the activity of sotorasib in …